
PARADIGM BIOCAPITAL ADVISORS LP
Latest 13F filing data - Q3 2025
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
![]() | ERAS | 13.56M | $29.56M |
![]() | OLMA | 6.79M | $66.51M |
![]() | RVMD | 6.22M | $290.63M |
![]() | EWTX | 6.17M | $100.08M |
![]() | NUVL | 5.27M | $455.70M |
![]() | ACLX | 4.65M | $381.68M |
![]() | MRUS | 4.37M | $411.79M |
![]() | URGN | 4.22M | $84.11M |
![]() | GMAB | 3.82M | $117.06M |
![]() | PCVX | 3.78M | $136.33M |
![]() | OCUL | 3.50M | $40.88M |
![]() | COGT | 3.16M | $45.33M |
![]() | TNGX | 3.09M | $25.92M |
![]() | JANX | 2.92M | $71.37M |
![]() | AGIO | 2.67M | $107.32M |
![]() | TARS | 2.67M | $158.42M |
![]() | VRDN | 2.61M | $56.31M |
![]() | CRNX | 2.55M | $106.24M |
![]() | SRRK | 2.01M | $74.84M |
![]() | EYPT | 2.01M | $28.56M |

Erasca, Inc.
ERAS
Shares Held
13.56M
Value
$29.56M

Olema Pharmaceuticals, Inc.
OLMA
Shares Held
6.79M
Value
$66.51M

Revolution Medicines, Inc.
RVMD
Shares Held
6.22M
Value
$290.63M

Edgewise Therapeutics, Inc.
EWTX
Shares Held
6.17M
Value
$100.08M

Nuvalent, Inc.
NUVL
Shares Held
5.27M
Value
$455.70M

Arcellx, Inc.
ACLX
Shares Held
4.65M
Value
$381.68M

Merus N.V.
MRUS
Shares Held
4.37M
Value
$411.79M

UroGen Pharma Ltd.
URGN
Shares Held
4.22M
Value
$84.11M

Genmab A/S
GMAB
Shares Held
3.82M
Value
$117.06M

Vaxcyte, Inc.
PCVX
Shares Held
3.78M
Value
$136.33M

Ocular Therapeutix, Inc.
OCUL
Shares Held
3.50M
Value
$40.88M

Cogent Biosciences, Inc.
COGT
Shares Held
3.16M
Value
$45.33M

Tango Therapeutics, Inc.
TNGX
Shares Held
3.09M
Value
$25.92M

Janux Therapeutics, Inc.
JANX
Shares Held
2.92M
Value
$71.37M

Agios Pharmaceuticals, Inc.
AGIO
Shares Held
2.67M
Value
$107.32M

Tarsus Pharmaceuticals, Inc.
TARS
Shares Held
2.67M
Value
$158.42M

Viridian Therapeutics, Inc.
VRDN
Shares Held
2.61M
Value
$56.31M

Crinetics Pharmaceuticals, Inc.
CRNX
Shares Held
2.55M
Value
$106.24M

Scholar Rock Holding Corporation
SRRK
Shares Held
2.01M
Value
$74.84M

EyePoint Pharmaceuticals, Inc.
EYPT
Shares Held
2.01M
Value
$28.56M
